Kaushik Paul - Seeking Alpha 'Kaushik Paul' Tag RSS Syndication from SeekingAlpha.com SeekingAlpha.com http://seekingalpha.com/author/kaushik-paul Expect FDA Approval of AMAG Pharmaceutical's Feraheme http://seekingalpha.com/article/145620-expect-fda-approval-of-amag-pharmaceutical-s-feraheme?source=feed 145620 By June 29, 2009, we expect the U.S. Food and Drug Administration (FDA) to decide on the marketing application of AMAG Pharmaceuticals, Inc.’s (AMAG) Feraheme (formerly known as Ferumoxytol), designed for the treatment of iron deficiency in anemia patients with chronic kidney disease (CKD), including dialysis dependent and non-dialysis dependent CKD patients.

  • Anemia is a condition of abnormally low levels of red blood cells (RBCs) in the blood and hemoglobin. Hemoglobin is a protein present in RBCs that is responsible for transporting oxygen to the body tissues. Deficiency of iron is one of the reasons behind the development of anemia in CKD patients.
  • Kidney disease eventually leads to kidney failure, a condition in which the kidney fails to perform its functioning of removing wastes from the body in the form of urine. Regular dialysis is required when both the kidneys have stopped working. Dialysis is a medical procedure of removing impurities and waste products from the blood, when the kidneys are unable to do so.

Feraheme, the lead pipeline candidate of AMAG, is being tested for the treatment of iron deficiency in anemia patients with CKD and as an agent to improve the visibility of internal bodily structures (contrast agent) during magnetic resonance angiography (MRA) in peripheral artery disease (PAD) patients. MRA is a non-invasive medical imaging technique, which is used to produce detailed three-dimensional images of the blood flow in the blood vessels.

]]> Fri, 26 Jun 2009 10:45:30 -0400 Kaushik Paul Kaushik Paul submits:

By June 29, 2009, we expect the U.S. Food and Drug Administration (FDA) to decide on the marketing application of AMAG Pharmaceuticals, Inc.’s (AMAG) Feraheme (formerly known as Ferumoxytol), designed for the treatment of iron deficiency in anemia patients with chronic kidney disease (CKD), including dialysis dependent and non-dialysis dependent CKD patients.

  • Anemia is a condition of abnormally low levels of red blood cells (RBCs) in the blood and hemoglobin. Hemoglobin is a protein present in RBCs that is responsible for transporting oxygen to the body tissues. Deficiency of iron is one of the reasons behind the development of anemia in CKD patients.
  • Kidney disease eventually leads to kidney failure, a condition in which the kidney fails to perform its functioning of removing wastes from the body in the form of urine. Regular dialysis is required when both the kidneys have stopped working. Dialysis is a medical procedure of removing impurities and waste products from the blood, when the kidneys are unable to do so.

Feraheme, the lead pipeline candidate of AMAG, is being tested for the treatment of iron deficiency in anemia patients with CKD and as an agent to improve the visibility of internal bodily structures (contrast agent) during magnetic resonance angiography (MRA) in peripheral artery disease (PAD) patients. MRA is a non-invasive medical imaging technique, which is used to produce detailed three-dimensional images of the blood flow in the blood vessels.


Complete Story »]]> AMAG FMS SNY SSRX WPI Kaushik Paul Companies Involved in the Treatment of Swine Flu http://seekingalpha.com/article/143693-companies-involved-in-the-treatment-of-swine-flu?source=feed 143693 Introduction

On June 11, 2009, the World Health Organization (WHO) declared the swine flu (swine influenza) outbreak as a global pandemic (worldwide outbreak of disease).

To date, 28,774 confirmed cases of swine flu have been reported in 74 countries across the world, including 13,000 confirmed cases in the U.S. The disease has caused 144 deaths throughout the world, including 27 deaths in the U.S. The origin of the swine flu outbreak can be traced to Mexico, where the virus has reportedly killed and infected 108 and 6,241 people respectively (data as of June 11, 2009).

]]> Wed, 17 Jun 2009 07:49:30 -0400 Kaushik Paul Kaushik Paul submits:

Introduction

On June 11, 2009, the World Health Organization (WHO) declared the swine flu (swine influenza) outbreak as a global pandemic (worldwide outbreak of disease).

To date, 28,774 confirmed cases of swine flu have been reported in 74 countries across the world, including 13,000 confirmed cases in the U.S. The disease has caused 144 deaths throughout the world, including 27 deaths in the U.S. The origin of the swine flu outbreak can be traced to Mexico, where the virus has reportedly killed and infected 108 and 6,241 people respectively (data as of June 11, 2009).


Complete Story »]]> AZN BAX BCRX GILD GSK MMM NVAX NVS RHHBY.PK SNY Kaushik Paul